文献速递其他结缔组织病自身炎症与 IgG4 相关病

深度免疫表型分析揭示自身免疫与自身炎症性疾病沿两个免疫轴分布,分别反映疾病炎症水平与类型

Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types.
PubMed 文献 · Ann Rheum Dis · 2024-04-11

研究对443例15种自身免疫或自身炎症性疾病患者及71名健康志愿者的血液行深度免疫表型分析,用13个流式细胞术Panel表征超600种固有和适应性免疫细胞群。无监督聚类将疾病分为5簇,主成分分析解卷积为两个免疫轴:第一轴由调节性T淋巴细胞(Tregs)中LAG3+与ICOS+比值驱动,按炎症水平区分疾病;第二轴由活化Tregs和3型固有淋巴样细胞(ILC3s)驱动,按受累组织类型区分疾病。作者据此将单维连续谱细化为同时体现疾病炎症水平和靶组织的连续谱,认为该分类有助于定义治疗。

要点

  • 443例15种自身免疫或自身炎症性疾病患者与71名健康志愿者行深度免疫表型分析。
  • 无监督聚类将疾病分为5簇,主成分分析解卷积为两个免疫轴。
  • 第一轴由Tregs中LAG3+/ICOS+比值驱动,按炎症水平区分疾病。

核心结论

  • 作者将自身免疫与自身炎症性疾病的单维连续谱细化为同时以疾病炎症水平和靶组织为特征的连续谱。
  • 作者认为该分类应有助于定义治疗。
  • 作者呼吁进一步研究Tregs中LAG3+/ICOS+平衡的作用以及ILC3s在自身免疫和自身炎症性疾病中的贡献。

研究设计与样本

  • 研究采集443例患15种自身免疫或自身炎症性疾病之一患者的血液和71名健康志愿者的血液。
  • 采用13个流式细胞术Panel进行深度表型分析,表征超过600种固有和适应性免疫细胞群。
  • 采用无监督和有监督分析识别疾病簇及其共有和特异性细胞参数。
  • 试验注册号NCT02466217。

主要发现

  • 无监督聚类将这些疾病分为5个簇。
  • 主成分分析将该聚类解卷积为两个免疫轴。
  • 第一轴由调节性T淋巴细胞(Tregs)中LAG3+与ICOS+的比值驱动,并按炎症水平区分疾病。
  • 第二轴由活化Tregs和3型固有淋巴样细胞(ILC3s)驱动,并按受累组织类型区分疾病。
  • 研究识别出由23个细胞群组成的特征,可准确刻画5个疾病簇。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者在结论中呼吁进一步研究Tregs中LAG3+/ICOS+平衡的作用以及ILC3s在自身免疫和自身炎症性疾病中的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Based on genetic associations, McGonagle and McDermott suggested a classification of autoimmune and autoinflammatory diseases as a continuum ranging from purely autoimmune to purely autoinflammatory diseases and comprising diseases with both components. We used deep immunophenotyping to identify immune cell populations and molecular targets characterising this continuum. METHODS: We collected blood from 443 patients with one of 15 autoimmune or autoinflammatory diseases and 71 healthy volunteers. Deep phenotyping was performed using 13 flow cytometry panels characterising over 600 innate and adaptive cell populations. Unsupervised and supervised analyses were conducted to identify disease clusters with their common and specific cell parameters. RESULTS: Unsupervised clustering categorised these diseases into five clusters. Principal component analysis deconvoluted this clustering into two immunological axes. The first axis was driven by the ratio of LAG3+ to ICOS+ in regulatory T lymphocytes (Tregs), and segregated diseases based on their inflammation levels. The second axis was driven by activated Tregs and type 3 innate lymphoid cells (ILC3s), and segregated diseases based on their types of affected tissues. We identified a signature of 23 cell populations that accurately characterised the five disease clusters. CONCLUSIONS: We have refined the monodimensional continuum of autoimmune and autoinflammatory diseases as a continuum characterised by both disease inflammation levels and targeted tissues. Such classification should be helpful for defining therapies. Our results call for further investigations into the role of the LAG3+/ICOS+ balance in Tregs and the contribution of ILC3s in autoimmune and autoinflammatory diseases. TRIAL REGISTRATION NUMBER: NCT02466217.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Tchitchek N, Binvignat M, Roux A, et al. Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types. Ann Rheum Dis. 2024. PMID: 38182406. doi:10.1136/ard-2023-225179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。